The British Association for Psychopharmacology (BAP) has releasedfresh guidelines on the best methods to treat substance abuse and addiction in the Journal of Psychopharmacology, published by SAGE. A panel of experts has carefully researched thenew, comprehensive guidelines, offering practitioners a detailedreview of the evidence to help them optimise their clinicaldecisions. The new BAP guidelines target treatment of substance abuse, harmfuluse, addiction and comorbidity with psychiatric disorders, andprimarily focus on pharmacological management. They represent asubstantial revision of the first BAP evidence-based guidelines for"the pharmacological management of substance misuse, addiction andcomorbidity," which were published in 2004. The new guidelines alsotake into account a number of recent documents from the UK NationalInstitute for Health and Clinical Excellence (NICE), and otherorganisations. The expert panel behind the updated guidelines searched for newevidence to offer practitioners recommendations based on the mostrespected and relevant research in the field. They consideredpharmacological management of alcohol, nicotine, opioids,benzodiazepines, stimulants, and associated co-morbidity with mental health problems and substance use or abuse in pregnancy. The experts alsoreviewed the latest research into pharmacotherapy for younger andolder people, those with personality disorder , and addressed 'club drugs,' cannabis and polydrug users. As wellas pharmacotherapies in common clinical use, the panel also coversthose with limited but promising evidence, and highlights importantareas of 'key uncertainty'. The new guidelines detail pharmacological interventions targetingthe following areas: withdrawal syndromes relapse prevention and abstinence maintenance reducing harms associated with illicit drug use by prescribing asubstitute drug or drugs (e.g. methadone maintenance treatment) preventing substance use complications (e.g. use of thiamine toprevent Wernicke's encephalopathy and Korsakoff's syndrome). "Our aim is to provide helpful and pragmatic guidelines forclinicians such as psychiatrists and GPs involved in prescribing topeople with substance abuse or harmful use alone and withpsychiatric comorbidity," says Anne Lingford-Hughes of ImperialCollege, London, lead author of these guidelines, who alsoco-authored the original 2004 BAP guidelines. "The update shouldalso be of interest to other practitioners in the substance misusefield, non-specialists, patients and their families," she adds. Additional References Citations. I am an expert from uv-led-lights.com, while we provides the quality product, such as Led Street Light Fixture Manufacturer , Led Plant Growing Lights, High Power UV Leds,and more.
Related Articles -
Led Street Light Fixture Manufacturer, Led Plant Growing Lights,
|